Form 4: Omnicell CEO Randall Lipps Acquires RSUs
Statement of Changes in Beneficial Ownership
Omnicell, Inc. reports that CEO Randall Lipps acquired 90,939 Restricted Stock Units (RSUs) on April 1, 2026, as part of the company's equity incentive plan.
Summary
- Randall A. Lipps, Chairman, President, and CEO of Omnicell, Inc., acquired 90,939 Restricted Stock Units (RSUs) on April 1, 2026.
- These RSUs were granted under the company's equity incentive plan.
- The acquisition of these RSUs does not involve a cash payment, as indicated by a price of $0.
- Following this transaction, Mr. Lipps beneficially owns a total of 535,531 shares.
- This total includes shares held directly, in trust with his wife, and in trust for his children.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents a standard executive compensation event and a CEO's continued commitment to the company through equity acquisition.
Positives
- CEO Randall Lipps has acquired a significant number of Restricted Stock Units (RSUs), indicating continued investment and commitment to the company.
- The RSUs vest over three years, with one-third vesting on the first anniversary and the remainder in equal installments on the second and third anniversaries, suggesting a long-term incentive structure.
- The acquisition of RSUs at a $0 price is a common incentive for executives, aligning their interests with shareholders.
Risks
- The vesting schedule of the RSUs means that a portion of the award is contingent on continued service and performance over the next three years.
- As with any equity-based compensation, the value of the RSUs is subject to the future performance of Omnicell's stock price.
Future Outlook
The vesting schedule for the acquired RSUs indicates a forward-looking commitment from CEO Randall Lipps, with portions vesting on the first, second, and third anniversaries of the grant date.
Industry Context
StockSavvy.ai notes that the granting and acquisition of Restricted Stock Units (RSUs) by senior executives is a standard practice in the healthcare technology industry to incentivize long-term performance and align executive interests with those of shareholders.
Stakeholder Impact
- Shareholders: The acquisition of RSUs by the CEO can be viewed positively as it aligns executive interests with long-term company performance.
- Employees: The RSU grant is part of the company's broader equity incentive plan, which can motivate and retain key talent.
Next Steps
- Vesting of one-third of the RSUs on the first anniversary of the grant date.
- Vesting of the remaining two-thirds of the RSUs in equal installments on the second and third anniversaries of the grant date.
Key Dates
| Date | Description |
|---|---|
| 04/01/2026 | Transaction Date for acquisition of RSUs. |
| 04/03/2026 | Date of signature for the filing. |
Keywords
Omnicell, OMCL, Randall Lipps, Restricted Stock Units, RSUs, Equity Incentive Plan, Executive Compensation, Form 4, SEC Filing, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.